You are here

  • Home
  • sickle cell disease

sickle cell disease

Bahrain successfully administers first CRISPR-based sickle cell treatment outside the US video

Bahrain successfully administers first CRISPR-based sickle cell treatment outside the US

  • Bahrain approved Casgevy for use on Dec. 2, 2023, becoming the second country globally and the first in the Middle East to do so
By Arab News ·

Opinion

Faisal J. Abbas
Crossing Jordan is not a good idea
Author
Dr. Abdellatif El-Menawy
What Gaza plan means for US-Egypt ties
Author
Dr. Diana Galeeva
German elections important for Middle East
Author
Peter Harrison
Who can we trust with the entire world’s data?
Author
Dr. Gyorgy Busztin
Unity, stability the key goals of Syria’s post-Baathist transition
Author
More in Opinion

Latest updates

Extremist militias in Lebanon ‘part of history,’ says Druze leader
Walid Jumblatt delivers a speech during a gathering in Ain Zhalta on June 25, 2023. (AFP)
Austria says stabbing attack suspect swore allegiance to Daesh
Austria says stabbing attack suspect swore allegiance to Daesh
SINDBAD Collective takes creativity for a road trip across Saudi Arabia and Bahrain
SINDBAD Collective takes creativity for a road trip across Saudi Arabia and Bahrain
Where We Are Going Today: ‘Flat Burger’ in Jeddah
Photo/Supplied
Deputy foreign minister meets Russian ambassador to Saudi Arabia
Waleed Elkhereiji (R) and Sergey Kozlov in Riyadh. (Supplied)

Recommended

Middle-East
Frankly Speaking: Is a Palestinian state more remote than ever?
Frankly Speaking: Is a Palestinian state more remote than ever?
Middle-East
How Syrians can pursue justice, fast-track peace in post-conflict era
How Syrians can pursue justice, fast-track peace in post-conflict era
Saudi Arabia
How Saudi Arabia is leveraging regenerative tourism to blend luxury with sustainability
How Saudi Arabia is leveraging regenerative tourism to blend luxury with sustainability

Search form

Print Edition
Read pdf version Subscribe now
© 2025 SAUDI RESEARCH & PUBLISHING COMPANY, All Rights Reserved And subject to Terms of Use Agreement.